Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 1 |
| Gross Profit | -55 | -52 | -58 |
| Operating Income | -87 | -101 | -172 |
| Net Income | -88 | -102 | -177 |
| EBITDA | -87 | -100 | -170 |
| EPS Diluted | -0.61 | -0.62 | -0.80 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 64 | 46 | 22 |
| Total Current Assets | 89 | 141 | 177 |
| Total Assets | 137 | 194 | 229 |
| Total Current Liabilities | 22 | 23 | 32 |
| Total Liabilities | 23 | 77 | 136 |
| Total Equity | 114 | 117 | 93 |
| Total Debt | 2 | 55 | 106 |
| Net Debt | -62 | 9 | 84 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -87 | -89 | -162 |
| Capital Expenditure | -1 | -1 | -0 |
| Free Cash Flow | -88 | -90 | -162 |
| Stock-Based Comp | 11 | 12 | 14 |
| Net Change in Cash | -62 | -18 | -24 |